Summit Therapeutics Inc. Common Stock (SMMT) stock analysis and AI prediction
The company facts of Summit Therapeutics Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $12.1 billion
- Size
- Large cap
- Employees
- 265
- Headquarters
- MIAMI, FL
- Listed since
- March 5, 2015
- Website
- smmttx.com
More Healthcare stocks
Other large cap stocks
Keep going
SMMT questions
What is the AI prediction for SMMT stock?
Each market day our model rates Summit Therapeutics Inc. Common Stock (SMMT) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the SMMT prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for SMMT?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see SMMT options?
The SMMT options page opens its calls and puts, with price, volume, implied volatility and the Greeks.